Prasugrel Bests Double-Dose Clopidogrel in Nonresponders
Автор: MDedge: news and insights for busy physicians
Загружено: 25 мар. 2012 г.
Просмотров: 3 827 просмотров
Patients with high platelet reactivity on standard-dose clopidogrel in conjunction with a drug-eluting stent for stable coronary disease obtain markedly greater platelet inhibition by switching to prasugrel at 10 mg/day than by doubling the clopidogrel dose to 150 mg/day, according to the Italian RESET trial. See the related story at http://tinyurl.com/cjqlryw

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: